peptide glp 1 GLP-1 Drugs and the Physiology of Metabolic Health GLP-1 Medications – Community Education

The FDA approved CV risk reduction as additional indication for Wegovy and obstructive sleep apnoea for Zepbound

D., Silver, W

4 GLP-1 receptor agonists and suicidality Semaglutide, dulaglutide, liraglutide, exenatide, and tirzepatide are administered daily or weekly, either by injection or in tablet form, with limited approval for children over 10 or 12 years of age, or only adults, for T2DM or weight reduction, offering additional benefits for the heart and kidneys

FDA approves weight loss drug Zepbound to treat obstructive sleep apnea The weight loss drug Zepbound has become the first prescription medication approved to treat obstructive sleep apnea

Look for Mounjaro on the list of drugs

Examples include Ozempic, Wegovy and Mounjaro